Follow ODP

As we revolutionize medications for everyone, everywhere, every time

Press Releases & Company Announcements

(August 15, 2025)
ODP Applauds Executive Order Strengthening the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR)
Rockville, MD, United States, August 15, 2025 โ€“ On Demand Pharmaceuticals (ODP), a leader in decentralized pharmaceutical medicine production, commends President Trumpโ€™s Executive Order strengthening the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), a decisive step toward securing a resilient, domestically sourced supply of active pharmaceutical ingredients to ensure essential medicines are available for the American people.
(August 14, 2025)
On Demand Pharmaceuticals Welcomes HHS Leadership to Showcase Breakthrough Domestic Pharmaceutical Manufacturing Capabilities
On Demand Pharmaceuticals (ODP) hosted senior officials from the U.S. Department of Health and Human Services (HHS) at its Centralized Production and Repackaging (CPR) facility inย Rockville, Maryland.
(April 11, 2025)
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
Ginkgo Bioworks and partners awardedย $29 millionย contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems

Additional Resources & Publications

(April 10, 2025)
Can decentralised manufacturing and predictive modelling end drug shortages?
A fragile global supply chain has contributed to widespread drug shortages but new technology, including predictive analytics and decentralised pharmaceutical manufacturing platforms, could be the keys to addressing this challenge.
(December 6, 2024)
OPCW global conference presentation by Luke Rogers, VP of Innovation, On Demand Pharmaceuticals
The Role of Artificial Intelligence in Advancing the Implementation of the Chemical Weapons Convention